Why Do New Therapies Succeed Or Fail In The Marketplace?

How can decisions made during the preclinical phase of drug development increase the chances of a product’s eventual success in a difficult marketplace?

To understand the factors that influence the early drug development journey for small molecules, Catalent and BioPharma Dive’s Brand Studio conducted an exclusive survey with participants from the pharma industry. Our industry report explores survey respondents’ opinions on why so many new drugs fail to deliver on their promise, and how they plan to avoid those pitfalls with their own compounds.

Click here to view eBook